The ROE as of July 2025 (TTM) for Adocia S.A. (ADOCY) is 127.55%

According to Adocia S.A.’s latest financial reports and current stock price. The company's current ROE is 127.55%. This represents a change of 51.25% compared to the average of 84.34% of the last 4 quarters.

Adocia S.A. (ADOCY) Historical ROE (quarterly & annually)

How has ADOCY ROE performed in the past?

The mean historical ROE of Adocia S.A. over the last ten years is 11.68%. The current 127.55% ROE has changed 992.36% with respect to the historical average. Over the past ten years (40 quarters), ADOCY's ROE was at its highest in in the June 2021 quarter at 340.75%. The ROE was at its lowest in in the December 2014 quarter at -605.59%.

Adocia S.A. (ADOCY) ROE by Quarter and Year

Discovering the peaks and valleys of Adocia S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Adocia S.A. (ADOCY) Average ROE

How has ADOCY ROE performed in the past?

The current ROE of Adocia S.A. (ADOCY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Adocia S.A. (ADOCY) ROE vs. Peers

How is ADOCY’s ROE compared to its peers?

Adocia S.A.’s ROE is greater than DiaMedica Therapeutics Inc. (-61.35%), greater than Milestone Pharmaceuticals Inc. (-197.83%), less than Seres Therapeutics, Inc. (26.67%), greater than Inhibikase Therapeutics, Inc. (-78.96%), greater than Oncolytics Biotech Inc. (-316.26%), greater than Anavex Life Sciences Corp. (-31.21%), greater than Cassava Sciences, Inc. (-46.29%), greater than INmune Bio, Inc. (-118.66%), greater than BioVie Inc. (-101.11%), greater than Cognition Therapeutics, Inc. (-194.42%), greater than Annovis Bio, Inc. (-188096.33%), greater than Iovance Biotherapeutics, Inc. (-49.71%), greater than Axsome Therapeutics, Inc. (-363.79%), greater than Novavax, Inc. (-115.51%), greater than Viking Therapeutics, Inc. (-14.41%), greater than Madrigal Pharmaceuticals, Inc. (-50.54%), greater than ImmunoGen, Inc. (-143.06%), greater than BioNTech SE (-4.04%), greater than CohBar, Inc. (-58.44%), greater than Ginkgo Bioworks Holdings, Inc. (-63.06%), greater than CRISPR Therapeutics AG (-20.08%),

Build a custom stock screener for Adocia S.A. (ADOCY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adocia S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adocia S.A. (ADOCY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adocia S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.